Parents are getting more and more anxious about their young children being in school unvaccinated. Now they may worry a little less as pharma giant Pfizer has asked the FDA on Thursday to authorize its COVID-19 vaccine with BionTech for kids ages 5-11. It was in September that Pfizer released new data that showed a … Continue reading “Pfizer Has Requested the FDA to Authorize Covid Vaccine for Kids 5-11”
Biotech & Pharma
Johnson & Johnson Will Seek FDA Authorization for a Booster Shot
According to a NY Times report, Johnson & Johnson will be seeking U.S. FDA authorization…
Merck Announces that Researches Shows its COVID-19 Pill Works Against Variants
Pharmaceutical giant Merck had some exciting news this week, revealing that laboratory studies show that…
Merck is Reportedly Close to Buying Acceleron Pharma
According to a Wall Street Journal report and sources familiar with the situation, pharma giant…
FDA Authorizes Booster Dose of Pfizer Inc for 65 and Older and Some Others
The U.S. Food and Drug Administration announced this week that it has authorized a booster…
Covid Vaccine Data for Kids Under 5 May Come in Late October Says Pfizer CEO
The world is still grappling with the coronavirus and many parents are anticipating when they…
Moderna Shares Rise as Morgan Stanley Boosts Price Target
Morgan Stanley has increased its price target on Moderna by 77% this week. Shares of…
Booster Shots From Pfizer Likely to Be Ready by September 20th
According to top infectious disease expert Dr. Anthony Fauci, Covid booster shots from pharma giant…
Pfizer Begins to Dose Patients in its Oral Covid-19 Drug Trial
Pharmaceutical giant Pfizer has now started to dose patients in its oral COVID-19 drug trial.…
Moderna is Looking to Get U.S. Authorization for its Covid-19 Vaccine Booster
Moderna asked the U.S. Food and Drug Administration (FDA) on Wednesday to allow the use…
Johnson & Johnson HIV Vaccine Fails Trial
In an effort to mitigate the HIV virus, Johnson & Johnson has a HIV vaccine…
Pfizer-BioNTech Covid Vaccine Gains FDA Approval
It was a big day on Monday for Pfizer and BioNTech, as the Food and…
Pfizer Skyrockets to a Record High for the First Time in Over Two Decades
Shares if biotech giant Pfizer were on a tear on Tuesday, climbing ot a record…
Pfizer Authorizes $1B for Covid-19 Oral Treatment
Pfizer's CEO Albert Bourla has said this week that the company has authorized $1 billion…